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The physicians task is to classify his patient's conditions to
predict their course and to take effective action at the most
appropriate time. Biochemical measurements often assist them
as a series of measurements to assess the development of a
disorder and the prognosis or as a single measurement to assess
a function or allocate the patient to a disease category (diagno-
sis). The proper selection, presentation, and interpretation of
data is an important part of any physician's activity.
The display of sequential data and the manipulation of single
values are very simple in mathematical terms, but the tedium of
calculation and plotting has prevented large-scale application.
There is, therefore, a need for quick, reliable, repetitive data
manipulation and display. These are ideal, if low level, tasks for
a computer. We will not discuss the computing aspect further,
but instead concentrate on the aims and advantages of data
manipulation and display in the particular context of the detec-
tion and management of renal disease. Initially, we will consid-
er the handling of sequential data which are collected from the
majority of patients attending renal clinics. Then we will discuss
the evaluation of single measurements collected to assess renal
function.
Sequential data
Laboratory results in a sequence are most often viewed
singly in relation to a few previous results and are not carefully
scrutinized for trends or patterns partly because they are not
tabulated. Sequential data are increasingly available from labo-
ratory systems as a cumulative report. However, in our opinion
a graphical display of sequential data is essential for interpreta-
tion, because the irregular intervals between results make it
difficult to assess patterns or trends even from tables. Manipu-
lation of the data before display can also have advantages. The
use of statistical analysis to evaluate trends or patterns is
considered elsewhere in this issue.
Display. The introduction of time converts data from a series
of snapshots into a film, which is best observed as a sequence
and not as individual frames. As a simple example of the
advantages of the display of data, Figure 1 shows the changes in
the serum creatinine in two renal transplant patients whose
renal function deteriorated when they were given a diuretic for
the fluid retention associated with an acute rejection episode.
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The deterioration was reversed after withdrawal of the drug,
either immediately (top panel) or after an interval of about 1
month (lower panel). The relationship between drug exposure
and the renal deterioration is obvious on the display but might
well have been missed without it.
Diuretics of various kinds are commonly prescribed for
patients with chronic renal failure or after renal transplantation
(particularly at the time of acute rejection). Renal impairment
due to the drugs can be easily obscured by other events and
may not be associated with obvious signs of an allergic response
[11. (In the examples we provide only patient 2 showed an
eosinophilia). In addition, some delay may occur before the
toxic effects of the drug are recognized (perhaps in patient 2
because of initial high-dose steroid therapy), or before an
improvement in renal function occurs after the drugs have been
withdrawn. A further example of this "dead time" is the 1-week
delay before renal function improves when mefenamic acid is
stopped in patients in whom it has caused renal failure [21.
These intervals of "dead time" are important in clinical
management.
Manipulation to linear trends. Transformed plasma creati-
nine. The response to diuretic withdrawal in patient 1 (Fig. 1) is
easily detected when the data are displayed because there had
been a steady increase in serum creatinine beforehand. A
change is most easily detected when it is superimposed on an
obvious and easily recognizable trend. In addition, if trends or
patterns are defined in the data, it may be possible to extrapo-
late the data to important thresholds and "action limits." The
type of trend or pattern is not critical, but rectilinear changes
with time are the easiest to interpret and use [31.
A plot of the reciprocal or the logarithm of serum creatinine
against time in progressive chronic renal failure is often rectilin-
ear (Fig. 2) [4, 5].
The two transforms, logarithm and reciprocal, have different
implications (see Appendix). A linear decrease in the reciprocal
with time implies a constant rate of decline of the GFR, with a
constant number of nephrons failing in unit time. On the other
hand, a linear increase in the logarithm of the serum creatinine
with time indicates a constant fractional decline in the GFR,
with a fixed proportion of surviving nephrons failing in unit
time. In Figure 2 the reciprocal changes more linearly with time
than the logarithm, and indeed the trend in the logarithm
suggests some acceleration in the loss of renal function begin-
ning in December 1980. A sequence which is linear as the
reciprocal must be nonlinear as the logarithm, and this nonlin-
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Fig. 1. Serial measurements of serum
creatinine in two renal allograft recipients.
Each data point represents a single reading of
serum creatinine, and the triangles high dose
steroid therapy. In patient 1 (top panel) the
second acute rejection episode responded to
corticosteroids, but thereafter a slow decline
in renal function occurred. A thiazide diuretic
was prescribed for the fluid retention
accompanying the rejection episode, and when
this was discontinued, renal function
progressively improved. In patient 2 (lower
panel) there were several acute rejection
episodes, which initially appeared to respond
to extra corticosteroid therapy but were
followed by progressive renal impairment. A
loop diuretic prescribed for fluid retention at
the time of one of these episodes was
associated with a marked eosinophilia, which
disappeared when it was withdrawn. Renal
function significantly improved after a short
delay, during which no other measures were
taken.
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earity would suggest an accelerating deterioration of function at
high values of plasma creatinine (at a fixed rate of decline of
GFR, the fraction of nephrons failing increases as the GFR
decreases).
Conversely, a curvilinear plot of plasma creatinine may be
linear when the data are transformed as the logarithm. In the
patient illustrated in Figure 3 an apparent amelioration in the
rate of decline of GFR is shown by the reciprocal plot. This
makes the interpretation of the effect of a therapy introduced
late in progressive renal failure difficult, if not impossible, from
serial plasma creatinine measurements.
The inevitable differences in the reciprocal and logarithmic
transform are important. For the purpose of detecting change
and making predictions, both transforms should be calculated
and displayed, and the one rendering the better straight line of
time should be used. This empiricism is justifiable as the
transform is used solely to define the trend and make predic-
tion. Deviations from a rectilinear trend allows the early
detection of intercurrent causes of renal deterioration, such as
drug toxicity or renal vein thrombosis, as described above. The
ability to detect small deviations from a trend restores a belief in
causality. There is so much "noise" in clinical affairs that the
relationship between a change in data and a definable event or
cause can easily be lost. Changes which would otherwise be
overlooked may, however, be clear cut after transformation and
display, and demand an explanation. In addition to this detec-
tion of added events, the transforms of serum creatinine allow
the course of renal failure to be viewed at a glance, and both the
clinicians and patient can be made aware, by extrapolation of
the data or by an appropriate calculation, of the time when renal
replacement therapy may well become necessary, and plans can
be made [6].
For simplicity we have presented the data as if creatinine
excretion and probably production were constant in progressive
renal failure, but there is, in fact, a consistent decline in the
amount excreted each 24 hr. This, and the implausability of
independent single nephron failure as the unit of function or
dysfunction, undermines the interpretation of changes in serum
creatinine (or its transform) as changes in GFR. However, GFR
is difficult to measure precisely in advanced renal disease and is
variable according to posture. For example, (Fig. 3) serum
creatinine or its transform remains the most useful index of
renal function [7].
It could be argued that information is lost when only the
transform is used. The "illness" effect of a slowly progressive
fall in GFR is presumably due to the increase in the blood
concentration of "uremic toxins," which are usually excreted
by glomerular filtration. The degree of retention of these
substances and of illness will in general parallel the increase in
the untransformed plasma creatinine. The value obtained for
the plasma creatinine is used for the two distinct pieces of
information in it. It is a guide to the clinical effect of any fall in
GFR, and, used as a reciprocal, it is a guide to the GFR. The
pattern of change in these two measurements in progressive
renal failure (Fig. 4), emphasizes the accelerating clinical deteri-
oration when function was lost at a steady rate, both patient and
chemistry showed dramatic changes when the GFR reached
very low levels although the rate of renal functional deteriora-
tion was unchanged.
The transformation of other biochemical measurements. It
has been pointed out recently that the transformation and
display of biochemical measurements other than the serum
creatinine may be of clinical value in the management of
patients with chronic renal disease [8]. Serum alkaline phospha-
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Fig. 2. The changes of serum creatinine with time in a patient wit/I
polycystic renal disease and progressive renal impairment. When
plotted as a reciprocal (middle panel), a rectilinear decline in GFR is
apparent, but in the logarithmic transform (lower panel) the plot is
curvilinear. However, there appears to be a significant change in slope
occurring in December 1980 which might indicate an intercurrent cause
of accelerated decline in renal function. In fact no change in manage-
ment was made at this time, and the clinical status of the patient was
stable.
tase is widely used as an index of renal osteodystrophy,
particularly secondary hyperparathyroidism, and as an index of
the response of the disorder to parathyroidectomy or vitamin D
metabolites [9]. The reciprocal or logarithm of the serum
alkaline phosphatase often changes linearly with time during
treatment (Fig. 5), and this gives a number of advantages in
patient management. Extrapolation of the data for example,
gives a prediction of the time at which the serum alkaline
phosphatase value will return to the normal range. Dangerous
hypercalcemia is most likely to occur at that time and can then
be prevented by reduction of the drug dosage. When there is no
risk of hypercalcemia, unnecessary clinic visits may be avoid-•
ed. The rate of decline of serum alkaline phosphatase may also
be useful as an indicator of an optimum dosage of vitamin D
metabolites. We found a mean half time of 3.3 weeks in 11
patients during treatment with 1-alpha hydroxycholecalciferol,
and this may be used for the assessment of treatment in new
patients.
Pattern. The display of sequential biochemical data may
create a series of more complex patterns, which nevertheless,
may appear repeatedly and, therefore, have to be considered
seriously. A well known example is the "spike" in the serum
creatinine after an acute renal transplant rejection (Fig. 1). The
recognition and use of patterns in data are of particular impor-
tance as they may be the only available approach in complex
clinical situations. There are less well recognized patterns of
change in the serum alkaline phosphatase after renal transplan-
Time, months
Fig. 3. The change in serum creatinine and measured GFR in a patient
with progressive renal impairment treated by a change of diet. The
difficulty in obtaining a reliable estimate of GFR at these low levels of
function is demonstrated. The reliability of serum creatinine as an index
of improvement of renal function depends on the observations made in
the text. (Reproduced with permission from [7].)
tation. Some typical patterns are shown in Figure 6. The bone
heals in a year or more after transplantation whereas the renal
osteodystrophy had taken much longer to develop. The changes
during healing may be characteristic for the predominant type
of renal osteodystrophy (say osteitis fibrosa or osteomalacia)
present beforehand, particularly where healing occurs against a
background of constant immunosuppression and stable renal
function. In a dialysis population an analysis of the patterns
may characterize the predominant bone disease in a particular
unit and indicate the impact of prophylactic treatments [101.
The use of patterns to describe complex clinical events is one
example of the benefit of organizing and presenting data at an
appropriate level of simplification. On the other hand, a com-
plex and mixed biological phenomenon may by chance fit a
simple mathematical function. Logarithmic transformation of
the data of Manuel et al [11] on the proteinuria which follows
renal transplantation, for example, shows a simple linear de-
cline of proteinuria with time (Fig. 7). However, the underlying
events are complex, with the contribution of albumin to the
proteinuria decreasing with time and the "tubular" component
increasing [11].
Consideration of the single measurement
When interpreting biochemical measurements, it is common-
ly assumed that the value of the measurement is proportional to
the function or severity of the disease being assessed, however,
such linear relationships are rarely verified. Interpretation is
most simple when the reported information derived from bio-
chemical measurement is not only proportional to the function
which is being assessed but also directly related to it and in our
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view the presentation of information with any other relationship
will involve unnecessary, and potentially dangerous, mental
gymnastics. The analytical result should be regarded as no more
than raw material, which should be manipulated mathematically
in any way which simplifies interpretation and enhances the
information contained within the stated result.
Plasma concentrations of urea and creatinine are routinely
used as single measurements in the assessment of GFR, and
they are generally regarded as necessary screening measure-
ments for patients admitted to an acute general hospital. The
results are often viewed suspiciously as the plasma urea may be
determined largely by factors other than the GFR. The plasma
creatinine is considered by many to be a crude measure of GFR
in young people with further limitations in the elderly. These
limitations may be less when data is correctly considered,
furthermore, direct but complex measurements such as creati-
nine clearance, themselves have less well recognized limita-
tions and may in practice be less precise than the simple
measurements.
Assessment of GFR in young adults. The view that the
plasma creatinine can give only a crude and insensitive assess-
ment of GFR, even in young people, is based on several
observations and conclusions: (1) The plasma creatinine is
insensitive to a reduction in GFR. (2) A direct measurement of
GFR is more precise than an indirect assessment such as the
plasma creatinine? (3) The plasma creatinine is determined by
body size, as well as by the GFR. (4) A direct measure of the
GFR is essential for certain clinical uses (such as the assess-
ment of drug dosage). (5) The plasma creatinine is increased by
recent meat intake.
Time, months
Fig. 5. The reciprocal of serum alkaline phosphatase and serum
calcium levels plotted against time for a patient under treatment with a
potent vitamin D derivative, There was a linear decline in the alkaline
phosphatase which is associated with the development of hypercalcae-
mia when the upper limit of the normal range is breached (•).
These last three criticisms can be answered: A recent intake
of meat is an avoidable event, a direct measure of GFR is not
necessary for the adjustment of drug dosage, and there is no
evidence that body size is a major determinant of the plasma
creatinine [12].
The major remaining argument against the plasma creatinine,
especially in young people, is that it is insensitive to a decline in
GFR. This conclusion is based on the well-established relation-
ship between plasma creatinine and GFR in health and disease,
which is that a substantial reduction in the GFR is associated
with relatively little increase in the plasma creatinine (Fig. 8).
The relative clinical usefulness of any two methods of assess-
ment depends, however, on the frequency of abnormal values
for each measurement in a group of patients with renal function
impairment. That frequency depends on the variation in each
measurement, as well as on the difference in the mean values.
This variation is relatively greater for the creatinine clearance
than for the plasma creatinine (Table 1). Our calculations
indicate clearly that the frequency of abnormal values will be
greater when plasma creatinine is used to look for renal
dysfunction than it is when the creatinine clearance is used [13].
For example, in a group of unselected young people who each
lose 25% of the average GFR, the frequency of a raised plasma
creatinine would be 38% and the frequency of low creatinine
clearance would be 21%. Doolan, Alpen, and Theil [12] and
Tobias, McLaughlin, and Hopper [14] in 1962 separately report-
ed the relation between plasma creatinine and creatinine clear-
ance illustrated in Figure 8. They each concluded that the
creatinine clearance is preferable among their patients with
renal disease; there were some with a low creatinine clearance
but a "normal" plasma creatinine. Duarte, Elveback, and
Liedtke [15] have made similar observations and drew the same
conclusions. In all three studies, however, there are even more
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Fig. 4. The changes with time in the GFR (as the reciprocal of plasma
creatinine) and the plasma creatinine, in a patient with steadily
progressive chronic renal failure.
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patients with "raised" plasma creatinine but a "normal" creati-
nine clearance [13]. All the observations, therefore, support the
conclusion that in practice, in contrast to theory, the plasma
creatinine is more useful than the creatinine clearance in
detecting a fall in GFR largely because of the error in measuring
creatinine excretion due to difficulties of urine collection, even
when patients are in a hospital.
When the measurement of creatinine clearance, or of plasma
creatinine, indicates that the GFR in a patient is low, and that
the results are outside the limits of the reference range, then the
patient probably has renal disease. The question which then
arises is by how much the GFR has been reduced in that
individual as a result of the disease. The problem in providing
an answer is the uncertainty about that person's GFR before he
became ill and the best guess of the original value usually made,
and one which would certainly be used for a group of patients,
is the mean value of the range in healthy young persons. The
individual's GFR, of course, could have started from any value
within the reference range. We suspect that often the person is
assumed to have a GFR that began at the bottom of the
reference range, which is the smallest possible change, rather
than from a GFR at the top of the range, which would be the
largest possible change. The best estimate is the difference
between the observed value and the mean of the reference
range; the confidence limits of this estimate are the range of the
reference values. The magnitude of the uncertainty can be
illustrated with examples based on the standard data for young
men shown in Table 1. A young man is found to have a
creatinine clearance (single estimate) of 60 ml/min, compared
with a reference range for single estimates of 70 to 170 mI/mm,
and a plasma creatinine of 180 j.tmoles/liter compared with a
reference range of 64 to 116 smoles/liter. The reduction of GFR
estimated as the ratio of the observed to the mean value in
Fig. 6. The course of the serum alkaline
phosphatase (transformed as a logarithm) in
time in three renal transplant patients. The
arrows indicate the time of transplantation.
There appears to be a short-lived suppression
of phosphatase soon after grafting, but
thereafter the patterns are variable. There may
be a linear decline without significant further
rise (top panel), a transient rise and then
linear decline (middle panel), or a persistent
and sustained rise. The last sequence outlines
a hill which contrasts with the slope of the
two other series.
healthy men would be 50%. However, the range of the possible
reduction given by the variation of the reference range is 15 to
65% based on creatinine clearance, and 36 to 65% based on
plasma creatinine. Even if error and variability in the individual
patient could be abolished (Table 1), the range of the possible
reduction would be 30 to 61% based on creatinine clearance,
and 39 to 62% based on plasma creatinine.
The difficulty in assessing the magnitude of the change in the
individual is the uncertainty about the value when he was well.
This rarely discussed uncertainty is a major limitation in our
ability to assess changes in GFR. If sequential values are
unavailable, it means that only crude interpretations are possi-
ble, and this would be the case even if the measurement of the
GFR in the individual was precise. For this reason alone, the
single nature of plasma creatinine is as adequate as an assess-
ment of GFR. What is required with the result, and is not often
provided, is some measure of the uncertainty or certainty that
there is a change from health in that individual.
If the plasma creatinine is measured, there is an advantage in
using the reciprocal of the value as an index of the GFR, since
this is more directly related to GFR and changes in the same
direction as GFR.
The plasma urea and the blood urea nitrogen are regarded as
very crude indices of the GFR and are being replaced rapidly by
the plasma creatinine. In the young chronically ill adult the
plasma urea is possibly as reliable as the plasma creatinine,
which is why it has continued as a screening procedure for
chronic renal disorder. In the acutely ill patient a raised plasma
urea is often not associated with a rise in plasma creatinine (a
fall in GFR) and is more usually due to an increased rate of urea
production.
Plasma creatinine as an assessment of GFR in the elderly.
The published surveys on plasma creatinine show that it is
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remarkably constant with advancing age in adults, although
men have in general higher levels than women at any age. There
is, by contrast, no doubt that the average creatinine clearance
and the inulin clearance decreases with age, and this has been
observed in longitudinal and cross-sectional studies [16]. The
constant plasma creatinine in the face of declining creatinine
clearance must indicate a fall in creatinine production, and this
has been attributed to the reduction in muscle mass known to be
present in the elderly. This explanation, although generally
adopted is unlikely, both because the reduction in muscle mass
is probably insufficient, and because it seems unlikely that a
perfect match of declining muscle mass and renal mass would
occur by chance. The constancy of the plasma creatinine is so
remarkable that it is tempting to regard it, or something
associated with it, as a controlled variable, with feedback
control of either the rate of creatinine production, or of com-
pensatory hypertrophy in the kidney as nephrons are lost.
Whatever the explanation, the constancy of the plasma
creatinine in the presence of a fall in GFR rules out the plasma
creatinine alone as a measurement of GFR in the elderly. Yet a
direct measurement of GFR is often unavailable in the elderly
because of the difficulties in obtaining a complete urine collec-
tion. One alternative is to use the mean GFR of a group of
healthy persons of the same age as the patients. These values
can be presented as a simple table, either in absolute units or as
a percentage of the value in men aged 45 (Table 2). The values
represent the most precise information we have, and the error
in assuming that each person in a group is at the mean is
probably no greater than the error of the estimate of the GFR if
we had measured it as the creatinine clearance. This table could
be used to estimate the GFR in a patient whose plasma
creatinine was within the range seen in healthy persons. If the
plasma creatinine exceeds the upper limit of this range then the
GFR must be less than expected for the patient's age. The
extent of this reduction in GFR can be estimated from the ratio
between the patient's plasma creatinine and the average plasma
creatinine in the healthy person. A plasma creatinine x times
the average value in healthy persons suggests that the GFR is
reduced to 1/x of the value expected at the patient's age.
Unlike the plasma creatinine the plasma urea increases with
age in adults, but the increase is less than expected from the
decline in GFR, presumably because the urea load (determined
by protein intake) and/or the percentage tubular reabsorption of
urea is reduced. The GFR is therefore adequate to meet the
usual demands for urea excretion in the elderly, but any
increase in the urea load can lead to a dramatic increase in
plasma urea. Any fall in GFR in the elderly leads to a rise in the
plasma urea relatively greater than the rise in the plasma
creatinine. This discrepancy will be exaggerated in the elderly
when there is extra muscle wasting because of disease or poor
nutrition, as this will lead to a further reduction in creatinine
production and plasma creatinine at a given GFR. it is, there-
fore, particularly difficult in the elderly to interpret the combi-
nation of a raised plasma urea and a normal or nearly normal
plasma creatinine. There is a need to identify some naturally
occurring component of plasma, the concentration of which is
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Table 1. Standard data for plasma creatinine and creatinine clearance
in young men (drawn from a review of nine publications [1])
Mean
Plasma creatinine
moles liter'
90
Creatinine clearance
ml min'
120
SD
Total 13 25
Within person 9 18
Analytical 6 11
Biological 6 14
Between persons 10 17
determined by GFR alone at any age. Serum 132 microglobulin
has been proposed to fill this need, but it can be increased as a
result of increased production as well as by reduced renal
clearance. Other low molecular weight proteins are under
investigation.
The assessment of GFR for the adjustment of drug doses.
One reason for estimating the GFR in patients of any age is the
need to adjust, when GFR is low, the dosage of drugs which are
largely excreted through the kidney. This is particularly impor-
tant in the elderly, because of the age-related reduction in GFR.
Direct measurement of GFR is imprecise and indeed impossible
in many clinical situations. Formulae are available for the
estimation of GFR from plasma creatinine, age, and body size.
Some of the formulae used are complex and most conveniently
handled by a computer. Increased complexity does not, howev-
er, necessarily bring a real and useful increase in precision,
particularly when there is such wide variation between persons
in the kinetics of any drug, and in the toxic drug levels. A simple
approach will probably suffice. The age-related reduction in
GFR can be estimated from data as in Table 2, and the disease-
related reduction in GFR from the increase in plasma creati-
nine. These two factors can be used to give an estimate of the
steady-state level of the drug if the patient was given a standard
dose. This estimated value can be compared with the toxic
threshold level for the drug, and, if necessary, a lower dose can
be chosen. Take, for example, a 75-year-old man with a plasma
creatinine of 250 moles/liter. The age-related reduction in
GFR is 62% so that for this reason alone the steady-state drug
level on a standard dose would be 1.6 (1/0.62)-fold that of a
young man. There is also a disease-related fall in GFR as
indicated by the rise in plasma creatinine, and this alone would
increase the drug level by a factor of 2.5 (250/100). The two
factors combined increase the drug level by a factor of 4 (2.5 x
1.6). The potential for using a computer to store either the
simple age-related data and the plasma creatinine to GFR
relationships, or the programs to perform the complex kinetic
calculations proposed by others, should increase the frequency
with which appropriate dose modifications are made.
We would emphasize however, that these complex calcula-
tions may have little advantage over the simple ones and have
the disadvantage that the principles involved are obscured. To
teach the principles and the simple calculations may be a more
effective method of decreasing drug toxicity in the elderly and
especially in those with renal disease.
Summary. There is more information in biochemical labora-
tory data than is generally appreciated; much can be gained by
display and manipulation of data.
Table 2. The average GFR (creatinine clearance) according to age in
adults (A) in absolute units (ml min') and (B) as a percentage of the
value in men aged 45 [6] calculated from the best straight line drawn
through the data
Age
45 55 65 75 85 95
A
Men 98 88 70 64 45 35
Women 76 74 60 49 41 34
B
Men 100 86 75 62 50 37
Women 84 73 62 50 40 28
Patients with renal disease are often under regular clinic
review so that many will have sets of sequential data. Display of
these data, which requires a computer if it is to be routine, will
reveal patterns and define trends which could be otherwise
missed or inadequately assessed. Trends are most useful if they
are recti-linear and several transforms of the data should be
tried to achieve this aim; for plasma creatinine the usual
transforms are the reciprocal and the logarithm. The choice of
transform is based on usefulness and not on any prior assump-
tion about the underlying pathophysiology.
More frequently, however, all that is available is a single
measurement, typically the simple plasma creatinine rather
than the more complex creatinine clearance. The problem is to
balance simplicity against precision and decide what the needs
and the reliablity of the interpretations of the data are. There is
an advantage in manipulation of the data and comparison with
standard data; and the possibilities were discussed for the
plasma creatinine; these tables are ideally suited to a laboratory
computer. It was suggested that complex calculations so easily
achieved with a computer should be avoided unless they bring
real gains, since complexity tends to hide the basic principles
involved.
Appendix
The relationship between GFR and serum creatinine concen-
tration is given by equations (1) and (2) (see below), where for
simplicity UV is assumed to be the constant in time. Equation
(1) gives the proportionality between the reciprocal of serum
creatinine and GFR.
When empirically there is a linear relationship between the
reciprocal of serum creatinine and time, it is described by
equation (3). The letter b is a constant and a the slope of the
line. By simple substitution from equation (1), we can find the
change of GFR with time [equation (4), and a value for the slope
of the line, a; that is, a = 2/'t'112P. It should be noted that t1,2 is
not a constant but the time for the plasma creatinine to fall to
half the initial value.
Where the logarithmic transform of serum creatinine is linear
with time, then equation (5) holds, which by development in
equation (6) and (7) gives an expression of the change of GFR
with time [equation (8)] and a value for a; that is, a = 0.693/t112.
In this instance the t1,2 is the time interval necessary for any
value on the curve to be halved.
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Abbreviations used in the equations are: GFR, glomerular
filtration rate at time t; GFRI, glomerular filtration rate at t 0;
U, urine creatinine concentration; V, urine excretion rate; P,
serum creatinine at time t; P, serum creatinine at t — 0.
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
GFR = UV/P = K x 1/P
In GFR = In K — in P
1/P = b — at = l/P — at
GFR = GFRI - K at
in P = at + b = at + in P1
In GFR = in K — (lnP1 + at)
= in GFR1 — at
GFR = GFR1 et
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